Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Annals of Pharmacotherapy|January 18, 2021
Cancer-Associated Venous Thromboembolism Treatment With Anti-Xa Versus Weight-Based Enoxaparin: A Retrospective Evaluation of Safety and EfficacyKayla Hart, Benjamin Andrick, Stacey Grassi, et al.Innovations in Pharmacy|August 21, 2024
Using a Preceptor Development Series in Writing and Publication to Improve Residency Research ManuscriptsDaniel Longyhore, Eric A Wright, Sarah Krahe Dombrowski, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 16, 2018
Randomized, Placebo-Controlled, Phase III Trial of Fosaprepitant, Ondansetron, Dexamethasone (FOND) Versus FOND Plus Olanzapine (FOND-O) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Highly Emetogenic Chemotherapy and Hematopoietic Cell Transplantation Regimens: The FOND-O TrialAmber B Clemmons, Julianne Orr, Benjamin Andrick, et al.Case Reports in Hematology|June 14, 2017
Thrombotic Microangiopathy Secondary to Intravenous Abuse of Opana® ERKamia Thakur, Vaibhav Agrawal, Ashley Kass, et al.World Neurosurgery|May 4, 2020
Case Report of Immuno-Oncotherapy (IO) Provoked Encephalitis Mimicking Brain Metastasis in a Patient with History of Traumatic Brain InjuryShane P Bross, Gino J Mongelluzzo, Andrew R Conger, et al.Neuro-Oncology Practice|May 31, 2021
Case series review of neuroradiologic changes associated with immune checkpoint inhibitor therapyNa Tosha N Gatson, Mina Makary, Shane P Bross, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 19, 2023
Early Increases in Blood Pressure and Major Adverse Cardiovascular Events in Patients With Renal Cell Carcinoma and Thyroid Cancer Treated With VEGFR TKIsVivek Narayan, Tao Liu, Yunjie Song, et al.Journal of Neuro-Oncology|July 1, 2020
Early imaging marker of progressing glioblastoma: a window of opportunityNa Tosha N Gatson, Shane P Bross, Yazmin Odia, et al.Blood|September 14, 2019
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyureaAbdulraheem Yacoub, John Mascarenhas, Heidi Kosiorek, et al.Science (New York, N.Y.)|April 30, 2020
Feasibility of blood testing combined with PET-CT to screen for cancer and guide interventionAnne Marie Lennon, Adam H Buchanan, Isaac Kinde, et al.Pageof 2